$DYN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Dyne Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Dyne Therapeutics, Inc.. Get notifications about new insider transactions in Dyne Therapeutics, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 27 2021 | DYN | Dyne Therapeutics, ... | Lubner David Charles | Director | Option Exercise | A | 19.56 | 19,596 | 383,298 | 19,596 | |
Mar 04 2021 | DYN | Dyne Therapeutics, ... | Farwell Wildon | Chief Medical Offic ... | Option Exercise | A | 17.77 | 250,000 | 4,442,500 | 250,000 | |
Mar 04 2021 | DYN | Dyne Therapeutics, ... | Farwell Wildon | Chief Medical Offic ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | MPM BIOVENTURES 2018, L.P. | 10% Owner | Option Exercise | C | 0.00 | 26,176 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | MPM BIOVENTURES 2018, L.P. | 10% Owner | Option Exercise | C | 0.00 | 70,492 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | MPM BIOVENTURES 2018, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,326,313 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | MPM BIOVENTURES 2018, L.P. | 10% Owner | Option Exercise | C | 0.00 | 275,932 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | MPM BIOVENTURES 2018, L.P. | 10% Owner | Option Exercise | C | 0.00 | 743,076 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | MPM BIOVENTURES 2018, L.P. | 10% Owner | Option Exercise | C | 0.00 | 13,980,992 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | MPM BIOVENTURES 2018, L.P. | 10% Owner | Buy | C | 0.00 | 91,081 | 0 | 91,081 | 0 to 91.1 K |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | MPM BIOVENTURES 2018, L.P. | 10% Owner | Buy | C | 0.00 | 245,279 | 0 | 245,279 | 0 to 245.3 K |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | MPM BIOVENTURES 2018, L.P. | 10% Owner | Buy | C | 0.00 | 4,614,943 | 0 | 4,614,943 | 0 to 4.6 M |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | VV Manager II, LLC | 10% Owner | Option Exercise | C | 0.00 | 192,102 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | VV Manager II, LLC | 10% Owner | Option Exercise | C | 0.00 | 6,922,803 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | VV Manager II, LLC | 10% Owner | Buy | P | 19.00 | 22,005 | 418,095 | 79,921 | 57.9 K to 79.9 K (+37.99 %) |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | VV Manager II, LLC | 10% Owner | Buy | C | 0.00 | 57,916 | 0 | 57,916 | 0 to 57.9 K |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | VV Manager II, LLC | 10% Owner | Buy | P | 19.00 | 792,995 | 15,066,905 | 2,880,125 | 2.1 M to 2.9 M (+37.99 %) |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | VV Manager II, LLC | 10% Owner | Buy | C | 0.00 | 2,087,130 | 0 | 2,087,130 | 0 to 2.1 M |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Lubner David Charles | Director | Option Exercise | C | 0.00 | 177,872 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Lubner David Charles | Director | Option Exercise | P | 0.00 | 177,872 | 0 | 177,872 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Lubner David Charles | Director | Option Exercise | A | 5.54 | 14,444 | 80,020 | 14,444 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Lubner David Charles | Director | Option Exercise | A | 5.54 | 11,156 | 61,804 | 11,156 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Lubner David Charles | Director | Buy | C | 0.00 | 53,625 | 0 | 53,625 | 0 to 53.6 K |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Logos Global Management LP | 10% Owner | Option Exercise | C | 0.00 | 2,668,089 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Logos Global Management LP | 10% Owner | Buy | P | 19.00 | 700,000 | 13,300,000 | 1,504,392 | 804.4 K to 1.5 M (+87.02 %) |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Logos Global Management LP | 10% Owner | Buy | C | 0.00 | 804,392 | 0 | 804,392 | 0 to 804.4 K |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Forbion Capital Fund IV Cooper ... | 10% Owner | Option Exercise | C | 0.00 | 5,336,179 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Forbion Capital Fund IV Cooper ... | 10% Owner | Option Exercise | C | 0.00 | 15,000,000 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Forbion Capital Fund IV Cooper ... | 10% Owner | Buy | C | 0.00 | 6,131,079 | 0 | 6,131,079 | 0 to 6.1 M |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | CureDuchenne Ventures, LLC | 10% Owner | Option Exercise | C | 0.00 | 2,000,000 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | CureDuchenne Ventures, LLC | 10% Owner | Buy | C | 0.00 | 602,972 | 0 | 602,972 | 0 to 603 K |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Klein Lawrence Otto | Director | Option Exercise | C | 0.00 | 35,574 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Klein Lawrence Otto | Director | Option Exercise | P | 0.00 | 35,574 | 0 | 35,574 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Klein Lawrence Otto | Director | Option Exercise | A | 5.54 | 14,444 | 80,020 | 14,444 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Klein Lawrence Otto | Director | Option Exercise | A | 5.54 | 11,156 | 61,804 | 11,156 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Klein Lawrence Otto | Director | Buy | C | 0.00 | 10,725 | 0 | 10,725 | 0 to 10.7 K |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Stehman-Breen Catherine | Director | Option Exercise | C | 0.00 | 35,574 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Stehman-Breen Catherine | Director | Option Exercise | P | 0.00 | 35,574 | 0 | 35,574 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Stehman-Breen Catherine | Director | Option Exercise | A | 5.54 | 14,444 | 80,020 | 14,444 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Stehman-Breen Catherine | Director | Option Exercise | A | 5.54 | 11,156 | 61,804 | 11,156 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Stehman-Breen Catherine | Director | Buy | C | 0.00 | 10,725 | 0 | 115,713 | 105 K to 115.7 K (+10.22 %) |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Rhodes Jason P | Director | Option Exercise | C | 0.00 | 5,336,179 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Rhodes Jason P | Director | Option Exercise | C | 0.00 | 20,000,000 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Rhodes Jason P | Director | Buy | C | 0.00 | 1,608,785 | 0 | 1,608,785 | 0 to 1.6 M |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Rhodes Jason P | Director | Buy | C | 0.00 | 6,029,726 | 0 | 8,140,130 | 2.1 M to 8.1 M (+285.71 %) |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Kersten Dirk | Director | Option Exercise | C | 0.00 | 5,336,179 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Kersten Dirk | Director | Option Exercise | C | 0.00 | 15,000,000 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Kersten Dirk | Director | Option Exercise | P | 0.00 | 5,336,179 | 0 | 5,336,179 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Kersten Dirk | Director | Option Exercise | P | 0.00 | 5,250,000 | 0 | 15,000,000 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Kersten Dirk | Director | Buy | C | 0.00 | 6,131,079 | 0 | 6,131,079 | 0 to 6.1 M |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Wellington Biomedical Innovati ... | 10% Owner | Option Exercise | C | 0.00 | 5,336,179 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Wellington Biomedical Innovati ... | 10% Owner | Buy | C | 0.00 | 1,608,785 | 0 | 1,608,785 | 0 to 1.6 M |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Atlas Venture Fund XI, L.P. | 10% Owner | Option Exercise | C | 0.00 | 5,336,179 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Atlas Venture Fund XI, L.P. | 10% Owner | Option Exercise | C | 0.00 | 20,000,000 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Atlas Venture Fund XI, L.P. | 10% Owner | Buy | C | 0.00 | 1,608,785 | 0 | 1,608,785 | 0 to 1.6 M |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | Atlas Venture Fund XI, L.P. | 10% Owner | Buy | C | 0.00 | 6,029,726 | 0 | 8,140,130 | 2.1 M to 8.1 M (+285.71 %) |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Option Exercise | C | 0.00 | 7,114,905 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | P | 19.00 | 660,000 | 12,540,000 | 2,805,045 | 2.1 M to 2.8 M (+30.77 %) |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | C | 0.00 | 2,145,045 | 0 | 2,145,045 | 0 to 2.1 M |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | HURWITZ EDWARD | Director | Option Exercise | C | 0.00 | 26,176 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | HURWITZ EDWARD | Director | Option Exercise | C | 0.00 | 70,492 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | HURWITZ EDWARD | Director | Option Exercise | C | 0.00 | 1,326,313 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | HURWITZ EDWARD | Director | Option Exercise | C | 0.00 | 275,932 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | HURWITZ EDWARD | Director | Option Exercise | C | 0.00 | 743,076 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | HURWITZ EDWARD | Director | Option Exercise | C | 0.00 | 13,980,992 | 0 | 0 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | HURWITZ EDWARD | Director | Option Exercise | P | 0.00 | 26,176 | 0 | 26,176 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | HURWITZ EDWARD | Director | Option Exercise | P | 0.00 | 70,492 | 0 | 70,492 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | HURWITZ EDWARD | Director | Option Exercise | P | 0.00 | 1,326,313 | 0 | 1,326,313 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | HURWITZ EDWARD | Director | Option Exercise | P | 0.00 | 96,576 | 0 | 275,932 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | HURWITZ EDWARD | Director | Option Exercise | P | 0.00 | 260,077 | 0 | 743,076 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | HURWITZ EDWARD | Director | Option Exercise | P | 0.00 | 4,893,347 | 0 | 13,980,992 | |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | HURWITZ EDWARD | Director | Buy | C | 0.00 | 91,081 | 0 | 91,081 | 0 to 91.1 K |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | HURWITZ EDWARD | Director | Buy | C | 0.00 | 245,279 | 0 | 245,279 | 0 to 245.3 K |
Sep 23 2020 | DYN | Dyne Therapeutics, ... | HURWITZ EDWARD | Director | Buy | C | 0.00 | 4,614,943 | 0 | 4,614,943 | 0 to 4.6 M |
Sep 18 2020 | DYN | Dyne Therapeutics, ... | HIGH SUSANNA GATTI | Chief Operating Off ... | Option Exercise | A | 19.00 | 111,405 | 2,116,695 | 111,405 | |
Sep 18 2020 | DYN | Dyne Therapeutics, ... | HIGH SUSANNA GATTI | Chief Operating Off ... | Grant | A | 0.00 | 35,904 | 0 | 35,904 | 0 to 35.9 K |
Sep 18 2020 | DYN | Dyne Therapeutics, ... | Beskrovnaya Oxana | See Remarks | Option Exercise | A | 19.00 | 59,857 | 1,137,283 | 59,857 | |
Sep 18 2020 | DYN | Dyne Therapeutics, ... | Beskrovnaya Oxana | See Remarks | Grant | A | 0.00 | 19,289 | 0 | 19,289 | 0 to 19.3 K |
Sep 18 2020 | DYN | Dyne Therapeutics, ... | Subramanian Romesh | Chief Scientific Of ... | Option Exercise | A | 19.00 | 128,185 | 2,435,515 | 128,185 | |
Sep 18 2020 | DYN | Dyne Therapeutics, ... | Subramanian Romesh | Chief Scientific Of ... | Grant | A | 0.00 | 41,309 | 0 | 566,249 | 524.9 K to 566.2 K (+7.87 %) |
Sep 18 2020 | DYN | Dyne Therapeutics, ... | McNeill Jonathan | See Remarks | Option Exercise | A | 19.00 | 52,787 | 1,002,953 | 52,787 | |
Sep 18 2020 | DYN | Dyne Therapeutics, ... | McNeill Jonathan | See Remarks | Grant | A | 0.00 | 17,012 | 0 | 36,910 | 19.9 K to 36.9 K (+85.50 %) |
Sep 18 2020 | DYN | Dyne Therapeutics, ... | Brumm Joshua T | See Remarks | Option Exercise | A | 19.00 | 320,781 | 6,094,839 | 320,781 | |
Sep 18 2020 | DYN | Dyne Therapeutics, ... | Brumm Joshua T | See Remarks | Grant | A | 0.00 | 107,027 | 0 | 107,027 | 0 to 107 K |
Sep 18 2020 | DYN | Dyne Therapeutics, ... | Scalzo Richard William | See Remarks | Option Exercise | A | 19.00 | 35,575 | 675,925 | 35,575 | |
Sep 18 2020 | DYN | Dyne Therapeutics, ... | Scalzo Richard William | See Remarks | Grant | A | 0.00 | 11,465 | 0 | 11,465 | 0 to 11.5 K |
Page: 1